▶ 調査レポート

世界のボーカルバイオマーカー市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Vocal Biomarker Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のボーカルバイオマーカー市場規模・現状・予測(2021年-2027年) / Global Vocal Biomarker Market Size, Status and Forecast 2021-2027 / QYR2104Z5960資料のイメージです。• レポートコード:QYR2104Z5960
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、97ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:New Technology
• 販売価格(消費税別)
  Single User¥546,000 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥819,000 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,092,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、ボーカルバイオマーカーのグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(周波数、振幅、エラー率、発声時間、ピッチ、その他)、用途別市場規模(病院、診療所、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・ボーカルバイオマーカーの市場動向
・企業の競争状況、市場シェア
・ボーカルバイオマーカーの種類別市場規模(周波数、振幅、エラー率、発声時間、ピッチ、その他)
・ボーカルバイオマーカーの用途別市場規模(病院、診療所、その他)
・ボーカルバイオマーカーの北米市場規模2016-2027(アメリカ、カナダ)
・ボーカルバイオマーカーのヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・ボーカルバイオマーカーのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・ボーカルバイオマーカーの中南米市場規模2016-2027(メキシコ、ブラジル)
・ボーカルバイオマーカーの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Beyond Verbal Communication、Sonde Health、IBM、Cogito)
・結論

Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs in the healthcare sector have led to the development of a unique diagnostic tool known as vocal biomarker, by combining the concept of biological markers with the aforementioned methodology to analyze personality traits.
These vocal biomarkers are deemed to have immense potential in diagnosing disease based on vocal cues. As part of ongoing breakthroughs, a group of researchers from the New York University Langone Medical Center is developing a machine learning-based artificial intelligence (AI) system that would be capable of analyzing various voice characteristics that include rhythm, tone, and pitch from patients.

In 2020, the global Vocal Biomarker market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2021-2026.
This report focuses on the global Vocal Biomarker status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Vocal Biomarker development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Vocal Biomarker Scope and Market Size
Vocal Biomarker market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vocal Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Frequency
Amplitude
Error Rate
Phonation Time
Pitch
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
Beyond Verbal Communication
Sonde Health
IBM
Cogito
Cogito

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vocal Biomarker Market Size Growth Rate by Type (2021-2027)
1.2.2 Frequency
1.2.3 Amplitude
1.2.4 Error Rate
1.2.5 Phonation Time
1.2.6 Pitch
1.2.7 Others
1.3 Market by Application
1.3.1 Global Vocal Biomarker Market Share by Application (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Vocal Biomarker Market Size
2.2 Vocal Biomarker Market Size by Regions
2.2.1 Vocal Biomarker Growth Rate by Regions (2021-2027)
2.2.2 Vocal Biomarker Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases

3 Key Players
3.1 Vocal Biomarker Revenue by Players (2020-2021)
3.2 Vocal Biomarker Key Players Headquaters and Area Served
3.3 Key Players Vocal Biomarker Product/Solution/Service
3.4 Date of Enter into Vocal Biomarker Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application
4.1 Global Vocal Biomarker Market Size by Type (2021-2027)
4.2 Global Vocal Biomarker Market Size by Application (2021-2027)

5 North America
5.1 North America Vocal Biomarker Market Forecast (2021-2027)
5.2 Vocal Biomarker Key Players in North America
5.3 North America Vocal Biomarker Market Size by Type
5.4 North America Vocal Biomarker Market Size by Application

6 Europe
6.1 Europe Vocal Biomarker Market Forecast (2021-2027)
6.2 Vocal Biomarker Key Players in Europe
6.3 Europe Vocal Biomarker Market Size by Type
6.4 Europe Vocal Biomarker Market Size by Application

7 Japan
7.1 Japan Vocal Biomarker Market Forecast (2021-2027)
7.2 Vocal Biomarker Key Players in Europe
7.3 Japan Vocal Biomarker Market Size by Type
7.4 Japan Vocal Biomarker Market Size by Application

8 Rest of World
8.1 China
8.1.1 China Vocal Biomarker Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Vocal Biomarker Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Vocal Biomarker Market Analysis
8.3.2 Key Players in India

9 International Player Profiles
9.1 Beyond Verbal Communication
9.1.1 Beyond Verbal Communication Company Details
9.1.2 Beyond Verbal Communication Description and Business Overview
9.1.3 Beyond Verbal Communication Vocal Biomarker Introduction
9.1.4 Beyond Verbal Communication Revenue in Vocal Biomarker Business (2020-2021)
9.1.5 Beyond Verbal Communication Recent Development
9.2 Sonde Health
9.2.1 Sonde Health Company Details
9.2.2 Sonde Health Description and Business Overview
9.2.3 Sonde Health Vocal Biomarker Introduction
9.2.4 Sonde Health Revenue in Vocal Biomarker Business (2020-2021)
9.2.5 Sonde Health Recent Development
9.3 IBM
9.3.1 IBM Company Details
9.3.2 IBM Description and Business Overview
9.3.3 IBM Vocal Biomarker Introduction
9.3.4 IBM Revenue in Vocal Biomarker Business (2020-2021)
9.3.5 IBM Recent Development
9.4 Cogito
9.4.1 Cogito Company Details
9.4.2 Cogito Description and Business Overview
9.4.3 Cogito Vocal Biomarker Introduction
9.4.4 Cogito Revenue in Vocal Biomarker Business (2020-2021)
9.4.5 Cogito Recent Development

10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints

11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Tables
Table 1. Global Vocal Biomarker Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Frequency
Table 3. Key Players of Amplitude
Table 4. Key Players of Error Rate
Table 5. Key Players of Phonation Time
Table 6. Key Players of Pitch
Table 7. Key Players of Others
Table 8. Global Vocal Biomarker Market Size Growth by Application (2021-2027) (US$ Million)
Table 9. Global Vocal Biomarker Market Size by Regions (2021-2027) (US$ Million)
Table 10. Global Vocal Biomarker Market Share by Regions (2021-2027)
Table 11. Market Top Trends
Table 12. Market Use Cases
Table 13. Global Vocal Biomarker Revenue by Players (2020-2021) (US$ Million)
Table 14. Global Vocal Biomarker Market Share by Players (2020-2021)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Vocal Biomarker Product Solution and Service
Table 17. Date of Enter into Vocal Biomarker Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Vocal Biomarker Market Size by Type (2021-2027) (US$ Million)
Table 20. Global Vocal Biomarker Market Size Share by Type (2021-2027)
Table 21. Global Vocal Biomarker Market Size by Application (2021-2027) (US$ Million)
Table 22. Global Vocal Biomarker Market Size Share by Application (2021-2027)
Table 23. North America Key Players Vocal Biomarker Revenue (2020-2021) (US$ Million)
Table 24. North America Key Players Vocal Biomarker Market Share (2020-2021)
Table 25. North America Vocal Biomarker Market Size by Type (2021-2027) (US$ Million)
Table 26. North America Vocal Biomarker Market Share by Type (2021-2027)
Table 27. North America Vocal Biomarker Market Size by Application (2021-2027) (US$ Million)
Table 28. North America Vocal Biomarker Market Share by Application (2021-2027)
Table 29. Europe Key Players Vocal Biomarker Revenue (2020-2021) (US$ Million)
Table 30. Europe Key Players Vocal Biomarker Market Share (2020-2021)
Table 31. Europe Vocal Biomarker Market Size by Type (2021-2027) (US$ Million)
Table 32. Europe Vocal Biomarker Market Share by Type (2021-2027)
Table 33. Europe Vocal Biomarker Market Size by Application (2021-2027) (US$ Million)
Table 34. Europe Vocal Biomarker Market Share by Application (2021-2027)
Table 35. Japan Key Players Vocal Biomarker Revenue (2020-2021) (US$ Million)
Table 36. Japan Key Players Vocal Biomarker Market Share (2020-2021)
Table 37. Japan Vocal Biomarker Market Size by Type (2021-2027) (US$ Million)
Table 38. Japan Vocal Biomarker Market Share by Type (2021-2027)
Table 39. Japan Vocal Biomarker Market Size by Application (2021-2027) (US$ Million)
Table 40. Japan Vocal Biomarker Market Share by Application (2021-2027)
Table 41. Key Players in China
Table 42. Key Players in Southeast Asia
Table 43. Key Players in India
Table 44. Beyond Verbal Communication Company Details
Table 45. Beyond Verbal Communication Description and Business Overview
Table 46. Beyond Verbal Communication Vocal Biomarker Product
Table 47. Beyond Verbal Communication Revenue in Vocal Biomarker Business 2020 and 2021
Table 48. Beyond Verbal Communication Recent Development
Table 49. Sonde Health Company Details
Table 50. Sonde Health Description and Business Overview
Table 51. Sonde Health Vocal Biomarker Product
Table 52. Sonde Health Revenue in Vocal Biomarker Business 2020 and 2021
Table 53. Sonde Health Recent Development
Table 54. IBM Company Details
Table 55. IBM Description and Business Overview
Table 56. IBM Vocal Biomarker Product
Table 57. IBM Revenue in Vocal Biomarker Business 2020 and 2021
Table 58. IBM Recent Development
Table 59. Cogito Company Details
Table 60. Cogito Description and Business Overview
Table 61. Cogito Vocal Biomarker Product
Table 62. Cogito Revenue in Vocal Biomarker Business 2020 and 2021
Table 63. Cogito Recent Development
Table 64. Vocal Biomarker Market Trends
Table 65. Vocal Biomarker Market Drivers
Table 66. Vocal Biomarker Market Challenges
Table 67. Vocal Biomarker Market Restraints
Table 68. Research Programs/Design for This Report
Table 69. Key Data Information from Secondary Sources
Table 70. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vocal Biomarker Market Share by Type in 2021 & 2027
Figure 2. Frequency Features
Figure 3. Amplitude Features
Figure 4. Error Rate Features
Figure 5. Phonation Time Features
Figure 6. Pitch Features
Figure 7. Others Features
Figure 8. Global Vocal Biomarker Market Share by Application in 2021 & 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Vocal Biomarker Report Years Considered
Figure 13. Global Vocal Biomarker Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 14. Global Vocal Biomarker Market Share by Regions (2020-2027)
Figure 15. Global Vocal Biomarker Market Share by Players in 2021
Figure 16. Global Vocal Biomarker Market Size Market Share by Type (2021-2027)
Figure 17. Global Vocal Biomarker Market Size Market Share by Application (2021-2027)
Figure 18. Global Vocal Biomarker Revenue Market Share by Application in 2021
Figure 19. North America Vocal Biomarker Market Size 2021-2027 (US$ Million)
Figure 20. Europe Vocal Biomarker Market Size 2021-2027 (US$ Million)
Figure 21. Japan Vocal Biomarker Market Size 2021-2027 (US$ Million)
Figure 22. Vocal Biomarker Market Size in China (2021-2027) (US$ Million)
Figure 23. Vocal Biomarker Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 24. Vocal Biomarker Market Size in India (2021-2027) (US$ Million)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed